Not just PTSD: reframing trauma as a public health issue

thom-milkovic-Q8yB-29GNTs-unsplash

This narrative review of trauma research from the past 15 years takes a lifespan, transdiagnostic, and global view; offering vital insights for clinicians, researchers, and policymakers.

[read the full story...]

Not just about cost: person-centred digital care for mental health-related sick leave

Welcome,Back,To,The,Office,On,A,Black,City-center,Sign

Can a nurse-led, digital mental health intervention for common mental disorders reduce sick leave and save money? This RCT from Sweden looked at cost, care, and what matters to patients.

[read the full story...]

Medical diagnosis increases the risk of depression: but who’s most vulnerable?

Older woman with grey hair sitting on park bench holding back in discomfort. Image captures concept of age, health, and lifestyle in serene outdoor setting.

Dona Mathews highlights a new study showing a doubled risk of depression after a medical diagnosis – especially in the first month post-diagnosis, for those who are hospitalised for their medical condition, those with multiple medical conditions, those over 60, and for women.

[read the full story...]

Feeding the mind: early signs that keto could help with bipolar disorder

Emerging research into the effects of a ketogenic diet have reported neuroprotective and anti-inflammatory mechanisms along with a positive metabolic effect

This pilot study explored how a ketogenic diet affects mood, metabolic health, and brain chemistry in people with bipolar disorder. The results are early, but they offer food for thought.

[read the full story...]

Putting oil on the fire: Do people with high inflammation react differently to immune stress?

feat

Inflammation is a key factor in depression for many people. This new RCT used an experimental immune challenge to explore how individuals with high inflammation respond differently—shedding light on a distinct biological subtype of depression.

[read the full story...]

GLP-1 receptor agonists and the brain: could these medications boost more than metabolism?

Variety,Of,Medicines,And,Drugs.medicine,And,Healthcare,Concept.variety,Of,Medicines

GLP1 drugs are already used to treat diabetes and support weight loss, but do they have any impact on mental health? This new meta-analysis looks at the evidence from 80 clinical trials.

[read the full story...]

Collaborative care for depression: what are the key components?

Collaborative care is a complex intervention for chronic disease that has been shown to be significantly more effective for depression than usual care. Yet, implementation in routine practice is rare.

Despite strong evidence, collaborative care remains underused in the NHS. This blog explores new findings that highlight which components of the model are most effective in reducing depression symptoms.

[read the full story...]

One therapy, many disorders: the strengths and limitations of CBT across mental health conditions

cbt for all

CBT is a cornerstone of mental health care, but how well does it really work across different disorders? This massive new meta-analysis offers some answers and raises new questions.

[read the full story...]

Talking about suicide in psychosis: does a targeted therapy make a difference?

illustration of mysterious man behind glass surface, creepy abstract concept

People with psychosis face unique risks around suicide, but most treatments aren’t designed with them in mind. This new RCT tested a targeted therapy that tackles those specific challenges. So what did it find?

[read the full story...]

GenAI chatbots can treat clinical level mental health symptoms

AI

With NHS services under strain, digital therapies are attracting more attention. This new study tested a generative AI chatbot in a national RCT and found significant clinical improvements. But are we ready for AI to join the therapy team?

[read the full story...]